Does TIPRANAVIR Cause Lipodystrophy acquired? 29 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Lipodystrophy acquired have been filed in association with TIPRANAVIR (Aptivus). This represents 7.2% of all adverse event reports for TIPRANAVIR.
29
Reports of Lipodystrophy acquired with TIPRANAVIR
7.2%
of all TIPRANAVIR reports
0
Deaths
11
Hospitalizations
How Dangerous Is Lipodystrophy acquired From TIPRANAVIR?
Of the 29 reports, 11 (37.9%) required hospitalization, and 11 (37.9%) were considered life-threatening.
Is Lipodystrophy acquired Listed in the Official Label?
Yes, Lipodystrophy acquired is listed as a known adverse reaction in the official FDA drug label for TIPRANAVIR.
What Other Side Effects Does TIPRANAVIR Cause?
Cholelithiasis (218)
Schizophrenia (217)
Nausea (216)
Pneumonia (216)
Vomiting (216)
Hypomania (151)
Hepatotoxicity (148)
Psychotic disorder (148)
Blood bilirubin increased (147)
Condition aggravated (147)
What Other Drugs Cause Lipodystrophy acquired?
LAMIVUDINE (383)
ZIDOVUDINE (313)
NEVIRAPINE (288)
STAVUDINE (283)
RITONAVIR (254)
LOPINAVIR\RITONAVIR (230)
DIDANOSINE (216)
TENOFOVIR DISOPROXIL (205)
EFAVIRENZ (203)
INDINAVIR (195)
Which TIPRANAVIR Alternatives Have Lower Lipodystrophy acquired Risk?
TIPRANAVIR vs TIRBANIBULIN
TIPRANAVIR vs TIROFIBAN
TIPRANAVIR vs TIRZEPATIDE
TIPRANAVIR vs TISAGENLECLEUCEL
TIPRANAVIR vs TISLELIZUMAB